Açıklama

Validation analyses confirm the reproducibility of key microbial metabolite associations with fibrosis severity across the Crohn's disease cohort.

Figure 8

Chart

Source Paper

Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.

EMBO molecular medicine (2024)

PMID: 39271960

DOI: 10.1038/s44321-024-00129-8

Cite This Figure

![Figure 8: Validation analyses confirm the reproducibility of key microbial metabolite associations with fibrosis severity across the Crohn's disease cohort.]()

> Source: Xuehua Li et al. "Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in." *EMBO molecular medicine*, 2024. PMID: [39271960](https://pubmed.ncbi.nlm.nih.gov/39271960/)

<figure>
  <img src="" alt="Validation analyses confirm the reproducibility of key microbial metabolite associations with fibrosis severity across the Crohn's disease cohort." />
  <figcaption>Figure 8. Validation analyses confirm the reproducibility of key microbial metabolite associations with fibrosis severity across the Crohn's disease cohort.<br>  Source: Xuehua Li et al. "Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in." <em>EMBO molecular medicine</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39271960/">39271960</a></figcaption>
</figure>

İlgili Kanıtlar

L-Glutamine için Crohn's Disease

Derece C · 3 çalışma